Blood and marrow testing to study metabolism in CLL
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This study measures how your body’s metabolism works in people with chronic lymphocytic leukemia (CLL). It uses blood tests, and for some people, a bone marrow sample, to better understand what’s happening and potentially guide future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be 18 years old or older
- Have a confirmed CLL diagnosis (either low or high disease burden)
- Be treatment-naive (you have not started CLL treatment yet)
- Be willing to sign informed consent to participate
- If you have the higher-burden group, be willing to have a bone marrow aspiration
- Avoid certain diet patterns (like Atkins, vegan, or ketogenic) and do not have a history of diabetes
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how the body makes blood cells in people with chronic lymphocytic leukemia (CLL), a related condition called monoclonal B-cell lymphocytosis (MBL), and in healthy volunteers matched by age. The goal is to understand differences that may help improve treatment or monitoring.
This trial studies whether limiting when you eat each day (time-restricted eating) can help people with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). It compares their response to people without cancer who follow the same eating pattern.
This study looks at how chronic lymphocytic leukemia (CLL) cells use energy in lymph nodes. It may help find new ways to treat CLL in the future.
This study tests whether a whole-food plant-based diet for 4 weeks can affect immune function and metabolism in people with early-stage CLL who have not yet had treatment.
This study looks at certain immune cells called macrophages in the bone marrow of people with chronic myelomonocytic leukemia (CMML). It aims to better understand the disease, which may help improve treatments in the future.
This study looks at how your 'biological age' (how old your body seems) affects how well you do on targeted therapy for chronic myeloid leukemia. It aims to personalize your care by combining age and frailty information.
Hear when a new Chronic Lymphocytic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.